By Calvin Palmer
The Beverly Hills fertility doctor who enabled Nadya Suleman to give birth to octuplets 18 months implanted too many embryos in another patient, resulting in the death of a fetus.
The Medical Board of California said in a revised filing that Dr Michael Kamrava acted with negligence when, In September 2008, he implanted seven embryos in a 48-year-old woman, identified as L.C.
Four of the embryos became viable, but the woman lost one during pregnancy and gave birth to triplets, one of whom has profound developmental delays, the board said.
The medical board found Kamrava implanted more than the medically recommended two embryos in a patient over 35 and “placed L.C. at great risk for high order gestation, which was confirmed by a quadruplet pregnancy that ended with catastrophic results.”
The board is empowered to revoke Kamrava’s license. He has been under investigation since Suleman’s multiple births.
The latest accusation of negligence was added on June 30 to an existing complaint regarding Suleman’s pregnancy.
The medical board has not disclosed the number of embryos Suleman had implanted but said the number was far in excess of recommendations and “beyond the reasonable judgment of any treating physician”.
Suleman has said six were implanted, and two of the embryos split. Her pregnancy has been under scrutiny since she gave birth in January 2009.
Kamrava was also accused of failing to refer another patient identified as H.L. for cancer screening, despite the patient’s history of cancer and finding cysts on her ovaries in an ultrasound.
After draining fluid from the patient’s cysts and having it tested for cancerous cells, Kamrava ruled out cancer on his own “rather than refer H.L. to a specialist for further evaluation,” according to the filing.
Kamrava continued with fertility treatments, performing an embryo transfer for the woman in January 2009, but the pregnancy did not take, the report states.
Afterward, the patient went to two more fertility specialists who both recommended she undergo surgery to rule out cancer.
Following the April 2009 surgery, H.L. was diagnosed with metastatic, stage III bilateral ovarian cancer and had to have her uterus, cervix, ovaries and fallopian tubes removed, the report states.
Kamrava is scheduled for a licensing hearing before the board to address the accusation on October 18.
[Based on a report by the Associated Press.]